Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Enrico Matteo Garanzini
Observed names:
E. Garanzini,
Enrico Garanzini
Institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institutions:
University of Milan,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Fondazione IRCCS Istituto Nazionale dei Tumori,
Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo
ORCID:
0000-0002-2582-9400
Observed ORCID:
0000-0002-2582-9400
OpenAlex ID:
A5074774054
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant
2020
·
Alessandro Cucchetti
, Matteo Serenari
, et al.
·
Journal of Hepatology
·
85
PDF
MRI based radiomics in nasopharyngeal cancer: Systematic review and perspectives using radiomic quality score (RQS) assessment
2021
·
Gaia Spadarella
, Giuseppina Calareso
, et al.
·
European Journal of Radiology
·
55
Treatment of collecting duct carcinoma: current status and future perspectives.
2014
·
Giuseppe Procopio
, Isabella Testa
, et al.
·
PubMed
·
36
Percutaneous microwave ablation of uterine fibroids: correlation between shrinkage and trend symptoms
2019
·
Anna Maria Ierardi
, Mario Petrillo
, et al.
·
Minimally Invasive Therapy & Allied Technologies
·
20
Sarcoidosis-like disease mimicking metastases during adjuvant ipilimumab therapy in advanced melanoma patient: CT scan and MRI help in managing difficult clinical decision
2020
·
Enrico Matteo Garanzini
, Davide Scaramuzza
, et al.
·
BJR|case reports
·
15
Targeted treatments in advanced renal cell carcinoma: focus on axitinib
2014
·
Giuseppe Procopio
, Elena Verzoni
, et al.
·
Pharmacogenomics and Personalized Medicine
·
13
PDF
Percutaneous cervical discectomy: retrospective comparison of two different techniques
2020
·
Anna Maria Ierardi
, Aldo Carnevale
, et al.
·
La radiologia medica
·
11
Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases.
2014
·
Giuseppe Procopio
, Elena Verzoni
, et al.
·
PubMed
·
11
Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma
2021
·
Ilaria Vicentin
, Cristina Mosconi
, et al.
·
European Radiology
·
10
Safety Profile and Treatment Response of Everolimus in Different Solid Tumors: An Observational Study
2014
·
Elena Verzoni
, Sara Pusceddu
, et al.
·
Future Oncology
·
10
Stability of Multi-Parametric Prostate MRI Radiomic Features to Variations in Segmentation
2023
·
Sithin Thulasi Seetha
, Enrico Garanzini
, et al.
·
Journal of Personalized Medicine
·
6
PDF
Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study
2020
·
Anna Maria Ierardi
, Aldo Carnevale
, et al.
·
Medical Oncology
·
6
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma
2023
·
Cristina Mosconi
, Joanne O’Rourke
, et al.
·
CardioVascular and Interventional Radiology
·
5
Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT
2021
·
Federica Scalorbi
, Giovanni Argiroffi
, et al.
·
Scientific Reports
·
5
PDF
Somatostatin Analogs in Association with Peptide Receptor Radionucleotide Therapy in Advanced Well-Differentiated NETs
2019
·
Natalie Prinzi
, Alessandra Raimondi
, et al.
·
Future Oncology
·
5
Cylindrical TGR as early radiological predictor of RLT progression in GEPNETs: a proof of concept
2024
·
Federica Scalorbi
, Enrico Matteo Garanzini
, et al.
·
Scientific Reports
·
4
A "blood theft" after liver transplantation: the role of interventional radiology in the management and treatment of splenic artery steal syndrome
2022
·
Federica Riva
, Enrico Matteo Garanzini
, et al.
·
Journal of Radiology Case Reports
·
3
PDF
Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE
2025
·
Marco Maccauro
, Mariarosaria Cuomo
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
2
PDF
Long Term Survival Analysis in a Cohort of 125 Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using Small Drug Eluting Beads
2021
·
Tommaso Cascella
, Enrico Matteo Garanzini
, et al.
·
CardioVascular and Interventional Radiology
·
2
Complete responses in advanced renal cell carcinoma: Utopia or real chance?
2013
·
Elena Verzoni
, Enrico Garanzini
, et al.
·
Clinical and Experimental Nephrology
·
2
Investigation of MicroRNAs as predictors of radioligand therapy response in gastroenteropancreatic neuroendocrine tumours
2026
·
Federica Scalorbi
, Enrico Matteo Garanzini
, et al.
·
Scientific Reports
·
1
PDF
Author Correction: Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT
2023
·
Federica Scalorbi
, Giovanni Argiroffi
, et al.
·
Scientific Reports
·
1
PDF
1105P Predictive factors of adverse events onset in GEPNET patients treated with PRRT
2021
·
F. Scalorbi
, G. Argiroffi
, et al.
·
Annals of Oncology
·
1
Enzalutamide activity in patients with metastatic castration resistant prostate cancer (mCRPC) previously responding to antiandrogen withdrawal syndrome (AWS): A preliminary report.
2014
·
Sergio Bracarda
, Giuseppe Procopio
, et al.
·
Journal of Clinical Oncology
·
1
Liver metastases as predictors of outcome in renal cell carcinoma (RCC) patients (pts) treated with first-line sunitinib (SU) and sorafenib (SO).
2014
·
Paolo Grassi
, Elena Verzoni
, et al.
·
Journal of Clinical Oncology
·
1
Show more works
View as search
Works count:
35
Citation count:
313
H-index:
10
I10-index:
10
Year
Topic
Type